Pulsus Group. is an internationally renowned peer-review publisher in scientific, technical, and medical journals established in the year 1984 with offices in Ontario, Canada and Hyderabad, India has acquired Andrew John Publishing and openaccessjournals.com to expand its Open Access Publishing through its 50+ journals in association with 20+ International medical and scientific societies.
Pulsus through its cmesociety.com is been very instrumental to provide an invaluable channel for scientists and researchers to exchange ideas and research by creating a forum for discussing the possibilities of future collaborations between universities, institutions, research bodies and organizations from different countries through international CME/CPD accredited conferences and meetings.
PULSUS GROUP is proud to present the 3rd International Congress on Microbiology, taking place in October 02-03, 2017 in Atlanta USA. The Conference will blend interactive workshops with scientific symposia and poster socials, offering participants a variety of opportunities to exchange ideas, debate-challenging topics and explore potential collaborations.
The conference also offers many presentations, including keynote lectures, symposia, and workshops, as well poster presentations. Travelling to the Atlanta from more than 100 countries around the world, the attendees will exchange ideas, and learn about how to apply the findings in clinical, laboratory, and public health settings. The conference is organized by the PULSUS, a non-profit organization whose mission is to develop the diagnosis, treatment, and prevention of infection-related diseases.
Why To Attend?
This conference is of interest to professionals in Microbiology from:
Abstract submission and registration are now open!
The Global microbiology market is increasing due to increase in pervasiveness of pathogenic diseases, growth in discovery of mutating and adapting microbes, and the growing need for rapid microbiological testing methods.
The microbiology laboratory has a whole array of diagnostics instruments used for scientific studies and diagnostic examination. These methods are used for the detection of viruses as well as a number of other diseases. Clinical microbiology testing is fundamental for identifying bacterial, fungal, and parasitic infections as well as for preventing epidemics. The rapid diagnostic testing market is the most needed after in the microbiology industry as it provides results in less than 30 minutes. Thus, immediate results are the major factors that will drive the microbiology market.There has been a raise in the number of infectious diseases across the globe. The factors such as the growth in incidence of HIV and tuberculosis as well as STD’s in developing countries along with the growth in respiratory diseases like influenza and Pneumonia in developed countries like Europe and USA will drive the microbiology market.
In 2013, the microbiology testing market accounted for 5% in the global IVD market and contributed $3556.7 million in 2013 to the IVD market, and is estimated to reach $4737.2 million by 2018, at a CAGR of 6.2% from 2013 to 2018.
The Americas commanded the largest share of 42% in the global microbiology market at $1485.02 million in 2013, and is expected to reach $1932.8 million by 2018, at a CAGR of 5.6% from 2013 to 2018.
The U.S. commanded the greatest share of 89% in the American Microbiology IVD market at $1320.4 million in 2012, and is expected to reach $1715.6 million by 2017, at a CAGR of 5.6% from the year 2013 to 2018.
Next to America, Europe occupies the 2nd largest market position. Germany commanded the largest share 20% at an estimated $223.7 million in 2013 and is expected to reach $272.5 million by the year 2018, at a CAGR of 4.2% from 2013 to 2018.
Asian Microbiology market is developing rapidly and will continue to grow in future. China commanded the largest share 53% at an estimated $177.1 million in 2013 and is expected to reach $334.5 million by the year 2018, at a CAGR of 14.2% from 2013 to 2018.
Epigenomics of Common Diseases :Epigenomics is the study of the complete set of epigenetic modifications on the genetic material of a cell, known as the epigenome. The field is analogous to genomics and proteomics, which are the study of the genome and proteome of a cell Epigenetic modifications are reversible modifications on a cell’s DNA or histones that affect gene expression without altering the DNA sequence maintenance is a continuous process and plays an important role in stability of eukaryotic genomes by taking part in crucial biological mechanisms like DNA repair. Two of the most characterized epigenetic modifications are DNA methylationand histone modification.
Diagnostic and General Microbiology: medical microbiology primarily focuses on the presence and growth of microbial infections in individuals, their effects on the human body and the methods of treating those infections. Diagnostic medical microbiology is the discipline that identifies etiologic agents of disease. The job of the clinical microbiology laboratory is to test specimens from patients for microorganisms that are, or may be, a cause of the illness. General Microbiology is the study of microscopic organisms, those being unicellular (single cell), multicellular (cell colony), or acellular (lacking cells). Microbiology encompasses numerous sub-disciplines including virology, mycology, parasitology, and bacteriology.
Genomics and Clinical Microbiology: Genomics is a discipline in genetics that applies recombinant DNA, DNA sequencing methods, and bioinformatics to sequence, assemble, and analyze the function and structure of genomes Advances in genomics have triggered a revolution in discovery-based research to understand even the most complex biological systems such as the brain. The field includes efforts to determine the entire DNA sequence of organisms and fine-scale genetic mapping. The field also includes studies of intragenomic phenomena such as heterosis, epistasis, pleiotropy and other interactions between loci and alleles within the genome
Infections & Immunity : immunity is the balanced state of having adequate biological defences to fight infection, disease, or other unwanted biological invasion, while having adequate tolerance to avoid allergy, and autoimmune diseases. . Immunity involves both specific and nonspecific components. The nonspecific components act either as barriers or as eliminators of wide range of pathogens irrespective of antigenic specificity. Other components of the immune system adapt themselves to each new disease encountered and are able to generate pathogen-specific immunity.
Vaccines and Synthetic Biology: A vaccine is a biological preparation that provides active acquired immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing micro-organism and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. The agent stimulates the body's immune system to recognize the agent as a threat, destroy it, and keep a record of it, so that the immune system can more easily recognize and destroy any of these micro-organisms that it later encounters. Synthetic biology is an interdisciplinary branch of biology and engineering. The subject combines various disciplines from within these domains, such as biotechnology, evolutionary biology, genetic engineering, molecular biology, molecular engineering, systems biology, biophysics, and computer engineering.
Current challenges in Food Microbiology: Recent scientific advances have created the opportunity for new insight into microbiological food safety issues. Our current policies and controls have served us well, but improvements are needed. With new information and tools, we can now create food safety management systems that use science to assess risk and focus our efforts in a flexible and effective manner. Knowing that change is inevitable, we can look ahead to spot new issues as they arise and be prepared to respond.
Bioterrorism is terrorism involving the intentional release or dissemination of biological agents. These agents are bacteria, viruses, or toxins, and may be in a naturally occurring or a human-modified form. This is the ongoing challenge in food microbiology where no one knows the causative agent nor the
Microbiome in Health and Disease: The gut micro biota in humans evolves throughout life and appears to play a pivotal role in both health and disease. In a healthy state, the gut micro biota have myriad positive functions, including energy recovery from metabolism of nondigestible components of foods, protection of a host from pathogenic invasion, and modulation of the immune system. A dysbiotic state of the gut micro biota is becoming recognized as an environmental factor that interacts with a host’s metabolism and has a role in pathological conditions.
Molecular Genetics and Cellular Microbiology: Molecular genetics is the field of biology and genetics that studies the structure and function of genes at a molecular level. The study of chromosomes and gene expression of an organism can give insight into heredity, genetic variation, and mutations. This is useful in the study of developmental biology and in understanding and treating genetic diseases. Cellular microbiology is the scientific study of the functions and properties of microbial cells. This discipline combines techniques and approaches of classic cell biology and microbiology.
Emerging Infections & Biotreats: New infections still present a threat to humanity. Novel pathogens often infect humans, but it is not yet well understood why only some pathogens acquire the ability to spread efficiently to other humans. An emerging infectious disease is an infectious disease whose incidence has increased in the past 20 years and could increase in the near future. Emerging infections account for at least 12% of all human pathogens. Public health emergencies caused by infectious threats have the potential to kill thousands or millions of people. These threats can emerge naturally as outbreaks or pandemics, such as influenza (pandemic and seasonal), severe acute respiratory syndrome (SARS), extremely-drug resistant (XDR) tuberculosis.
Biofilm formation and Applied Microbiology: A biofilm is any group of microorganisms in which cells stick to each other on a surface. These adherent cells are frequently embedded within a self-produced matrix of extracellular polymeric substance. Biofilms can be formed by a single bacterial species, but biofilms more often consist of many species of bacteria, as well as fungi, algae, protozoa, debris, and corrosion products. Essentially, a biofilm may form on any surface exposed to bacteria and some amount of water. Applied microbiology is a branch deals with application of microorganisms in the field of science for the production of human beneficial products such as medicines, antibiotics, vaccines, enzymes, biotechnological engineered products and also in food technology as fermentation products.
New Antibacterial Agents & Stewardship: Antimicrobial resistance refers to microbe’s ability to change and become less susceptible to drugs. The development of antimicrobial drugs (antibiotics, antivirals, antifungals and antiparasitics) to treat otherwise life-threatening infections has been one of the most notable medical achievements in human history. Antimicrobial stewardship refers to coordinated interventions designed to improve and measure the appropriate use of antimicrobials by promoting the selection of the optimal antimicrobial drug regimen, dose, duration of therapy, and route of administration
Healthcare-associated & Nosocomial Infections, Infection Control: Hospital-acquired infection also known as nosocomial infection is an infection that is contracted from the environment or staff of a healthcare facility. It can be spread in the hospital environment, nursing home environment, rehabilitation facility, clinic, or other clinical settings. Infection is spread to the susceptible patient in the clinical setting by a number of means. Health care staff can spread infection, in addition to contaminated equipment, bed linens, or air droplets. Controlling nosocomial infection is to implement Quality assurance / Quality control measures to the health care sectors, and evidence-based management can be a feasible approach.